Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

National Pharmaceutical Council to Host Conference on Measuring Health Care Value and Impact on Patient Care

Assessing Value: Promise and Pitfalls to Be Held Sept. 29 in Washington, DC

(Washington, DC, September 15, 2016)—The National Pharmaceutical Council (NPC) will bring together health care stakeholders on September 29 for a conference, “Assessing Value: Promise and Pitfalls,” to examine one of the most controversial issues in health care today: how to measure the value of a medical treatment and its impact on patient care.

Value assessment is a new and evolving field, with the potential to have a tremendous impact on patient treatment decisions, as well as on coverage and reimbursement decisions. Multiple assessment frameworks—such as the Institute for Clinical and Economic Review, DrugAbacus and the American Society of Clinical Oncology—have emerged in the United States in response to several factors, including an increased focus on patient-centered care, alternative payment models intended to incentivize health care value, and public attention on new high-priced therapies.

“The tools and solutions we develop to move health care toward a system driven by value must be grounded in sound science and centered on the needs and values of patients. Well-structured value assessment frameworks that incorporate the full value and benefits of a medical innovation can help achieve this,” said Dan Leonard, NPC president. “It is critically important to get this right, and much work remains to be done before existing frameworks will be ready for broader use in the United States.”

WHO: The National Pharmaceutical Council

WHAT: NPC will host a conference exploring existing value assessment frameworks, their challenges, and current multiple myeloma treatment assessments conducted using four different frameworks. NPC also will present new research comparing existing frameworks to best practices. A broad range of stakeholders will share their perspectives on the research, uncovering the lessons learned to date and how best to advance the field of value assessment.

Follow along on Twitter using #npcvalueconf.

WHERE:

The Liaison Capitol Hill
415 New Jersey Ave., NW
Metropolitan Ballroom (Lobby Level)
Washington, DC 20001

NPC also will broadcast the conference live online.

WHEN: Thursday, September 29, 2016, 8:30 am to 4 pm

REGISTER: Register to attend in-person or watch online.

For background information about value assessment, view NPC’s Current Landscape: Value Assessment Frameworks, which compares the main frameworks currently in development, our Guiding Practices for Patient-Centered Value Assessment, and our blog series exploring various aspects of value assessment.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation’s major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.

# # #

Blog Post

NPC Value Conference Sparks Dialogue to Define, Understand Value in Health Care

How do we measure the value of a medical intervention, its benefits to patients, and the associated costs to patients, payers and society as a whole...
Blog Post

Putting Patients First® in the Value Equation: An Interview With the National Health Council’s Dr. Eleanor Perfetto

National Pharmaceutical Council President Dan Leonard caught up this week with Eleanor Perfetto, PhD, MS, Senior Vice President of Strategic...
Commentary and Testimony Page

Chain Drug Review – Commentary: "Considering Value in Health Care"

This commentary was originally published in the July 25, 2016, issue of Chain Drug Review.By: Dan Leonard, President, National Pharmaceutical...
Blog Post

NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Assessment Framework

The National Pharmaceutical Council (NPC) today submitted comments to the Institute for Clinical and Economic Review (ICER) about ways to improve its...
Press Release

National Pharmaceutical Council Remains Engaged With the Institute for Clinical and Economic Review, Continuing Constructive Dialogue to Improve Value Assessment Frameworks

(Washington, DC, September 8, 2016)—The National Pharmaceutical Council (NPC) Board of Directors has agreed to renew the health policy research...
Press Release

NPC Takes Issue With ICER's Mischaracterization of Funding Sources

The National Pharmaceutical Council (NPC) takes exception to the Institute for Clinical and Economic Review’s (ICER) continued portrayal of us as an...
Commentary and Testimony Page

Chain Drug Review – Commentary: "Considering Value in Health Care"

This commentary was originally published in the July 25, 2016, issue of Chain Drug Review.By: Dan Leonard, President, National Pharmaceutical...
Commentary and Testimony Page

NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Framework

September 12, 2016Steven D. Pearson, MD, MSc, FRCP President Institute for Clinical and Economic Review One State Street, Suite 1050 Boston, MA 02109...
Commentary and Testimony Page

Thinking Differently About How We Assess Health Value

Health care stakeholders remain divided over how the value of health care treatments—especially medicines—should be assessed, and whether existing...
Blog Post

NPC Value Conference Sparks Dialogue to Define, Understand Value in Health Care

How do we measure the value of a medical intervention, its benefits to patients, and the associated costs to patients, payers and society as a whole...
Blog Post

Putting Patients First® in the Value Equation: An Interview With the National Health Council’s Dr. Eleanor Perfetto

National Pharmaceutical Council President Dan Leonard caught up this week with Eleanor Perfetto, PhD, MS, Senior Vice President of Strategic...
Blog Post

NPC Submits Comments to Institute for Clinical and Economic Review on Its Value Assessment Framework

The National Pharmaceutical Council (NPC) today submitted comments to the Institute for Clinical and Economic Review (ICER) about ways to improve its...
Blog Post

Moving Value Frameworks from Fledgling to Functional

Defining value in health care – especially as our health system shifts its focus from rewarding the volume of services provided to rewarding the...
Current Landscape: Value Assessment Frameworks

Current Landscape: Value Assessment Frameworks

This paper builds on Neumann and Cohen's informative comparison of value assessment frameworks...